Loading...

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

SFOSF•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$2.70
$0.00(0.00%)
U.S. Market opens in 14h 13m

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SFOSF) Stock Overview

Explore Shanghai Fosun Pharmaceutical (Group) Co., Ltd.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap7.1B
P/E Ratio11.84
EPS (TTM)$0.19
ROE0.09%
Fundamental Analysis

AI Price Forecasts

1 Month$2.97
3 Months$2.71
1 Year Target$3.41

SFOSF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SFOSF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 68.68, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $3.41.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 11.84 and a market capitalization of 7.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
10.66%
3-Month Change
-2.88%
6-Month Change
-18.18%
Year-to-Date (YTD) Change
8.00%
1-Year Change
38.46%
3-Year Change
-9.40%
5-Year Change
-40.40%
All-Time (Max) Change
-20.35%

Contact Information

https://www.fosunpharma.com
86 21 3398 7000
Building A, Shanghai, NaN, 200233

Company Facts

40,557 Employees
IPO DateApr 21, 2014
CountryCN
Actively Trading

Frequently Asked Questions